394 related articles for article (PubMed ID: 24661979)
1. Combination of LC-MS/MS aldosterone and automated direct renin in screening for primary aldosteronism.
Juutilainen A; Savolainen K; Romppanen J; Turpeinen U; Hämäläinen E; Kemppainen J; Moilanen L; Pulkki K
Clin Chim Acta; 2014 Jun; 433():209-15. PubMed ID: 24661979
[TBL] [Abstract][Full Text] [Related]
2. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
3. Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism.
Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
Clin Chem; 2020 Mar; 66(3):483-492. PubMed ID: 32068832
[TBL] [Abstract][Full Text] [Related]
4. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
J Clin Endocrinol Metab; 2018 Nov; 103(11):3965-3973. PubMed ID: 30137438
[TBL] [Abstract][Full Text] [Related]
6. The ratios of aldosterone / plasma renin activity (ARR) versus aldosterone / direct renin concentration (ADRR).
Glinicki P; Jeske W; Bednarek-Papierska L; Kruszyńska A; Gietka-Czernel M; Rosłonowska E; Słowińska-Srzednicka J; Kasperlik-Załuska A; Zgliczyński W
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1298-305. PubMed ID: 25143328
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
[TBL] [Abstract][Full Text] [Related]
9. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
[TBL] [Abstract][Full Text] [Related]
11. A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin.
Dorrian CA; Toole BJ; Alvarez-Madrazo S; Kelly A; Connell JM; Wallace AM
Ann Clin Biochem; 2010 May; 47(Pt 3):195-9. PubMed ID: 20392751
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
Burrello J; Monticone S; Buffolo F; Lucchiari M; Tetti M; Rabbia F; Mengozzi G; Williams TA; Veglio F; Mulatero P
J Hypertens; 2016 May; 34(5):920-7. PubMed ID: 27031933
[TBL] [Abstract][Full Text] [Related]
13. Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry.
Fischer E; Reuschl S; Quinkler M; Rump LC; Hahner S; Bidlingmaier M; Reincke M;
Horm Metab Res; 2013 Jul; 45(7):526-31. PubMed ID: 23613013
[TBL] [Abstract][Full Text] [Related]
14. The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma.
Rossi GP; Barisa M; Belfiore A; Desideri G; Ferri C; Letizia C; Maccario M; Morganti A; Palumbo G; Patalano A; Roman E; Seccia TM; Pessina AC; Mantero F;
J Hypertens; 2010 Sep; 28(9):1892-9. PubMed ID: 20683340
[TBL] [Abstract][Full Text] [Related]
15. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
[TBL] [Abstract][Full Text] [Related]
16. One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):388-94. PubMed ID: 22689101
[TBL] [Abstract][Full Text] [Related]
17. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
Lonati C; Bassani N; Gritti A; Biganzoli E; Morganti A
J Hypertens; 2014 Mar; 32(3):627-34. PubMed ID: 24445391
[TBL] [Abstract][Full Text] [Related]
18. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J
J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197
[TBL] [Abstract][Full Text] [Related]
19. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
Jansen PM; van den Born BJ; Frenkel WJ; de Bruijne EL; Deinum J; Kerstens MN; Smulders YM; Woittiez AJ; Wijbenga JA; Zietse R; Danser AH; van den Meiracker AH
J Hypertens; 2014 Jan; 32(1):115-26. PubMed ID: 24018605
[TBL] [Abstract][Full Text] [Related]
20. Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up.
Pizzolo F; Salvagno G; Caruso B; Cocco C; Zorzi F; Zaltron C; Castagna A; Bertolone L; Morandini F; Lippi G; Olivieri O
J Hum Hypertens; 2017 Dec; 31(12):826-830. PubMed ID: 29115296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
